Glycopyrrolate and Lumateperone interaction
Glycopyrrolate and Lumateperone: both prescribing labels mention this combination without an instruction to avoid it or change the dose.
Mentioned, no instruction to avoid. Worth knowing; rarely a reason to change anything on its own.
What the FDA labels say
From the Glycopyrrolate label · effective 2026-02-17
Co-administration of antipsychotics with glycopyrrolate may lead to worsening of tardive dyskinesia.
From the Lumateperone (CAPLYTA) label · effective 2025-06-20
Strenuous exercise, exposure to extreme heat, dehydration, and anticholinergic drugs may contribute to an elevation in core body temperature.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.